Related Experiment Video
Updated: Jan 16, 2026

04:38
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
10.8K
The Immunologic Underpinnings of Post-Stroke Depression
Nina Vindegaard Sørensen1,2,3, Anders Hougaard1,4, Christina Kruuse2,4
1Department of Neurology, Herlev-Gentofte Hospital, Herlev, Denmark.
Biological Psychiatry Global Open Science
|September 29, 2025
Summary
Post-stroke depression, affecting 30% of stroke survivors, is linked to immune system changes. Understanding these immunologic alterations is key to developing new treatments for this common condition.
Area of Science:
- Neuropsychiatry
- Immunology
- Neurology
Background:
- Post-stroke depression (PSD) affects approximately 30% of stroke patients, significantly impairing rehabilitation and quality of life.
- Stroke triggers acute central nervous system immune activation and peripheral immunologic alterations.
- Existing evidence links immunologic alterations to non-stroke-related depression, suggesting a role in PSD.
Purpose of the Study:
- To review and evaluate current evidence on immunologic alterations associated with depression, stroke, and PSD.
- To outline knowledge and hypotheses regarding stroke-related immunologic changes and their link to PSD risk.
- To identify future research directions and therapeutic potentials for PSD.
Main Methods:
- Narrative review of existing literature.
- Evaluation of immunologic alterations in cerebrospinal fluid and blood.
- Analysis of factors including infections, blood-brain barrier integrity, autoimmunity, brain imaging, and neuroendocrine-immune axes.
Main Results:
- Stroke is associated with significant central and peripheral immune system activation.
- Multiple immunologic factors, including infections and neuroinflammation, may contribute to PSD.
- Bidirectional interactions between the immune system and the brain are implicated in PSD pathophysiology.
Conclusions:
- Post-stroke depression likely involves a multifactorial immunologic pathophysiology.
- Further research is crucial to elucidate the complex immune mechanisms underlying PSD.
- Targeting immunologic pathways may offer novel therapeutic strategies for PSD, despite associated challenges.

